Antibody fucosylation predicts disease severity in secondary dengue infection is a research paper published in Science (2021). On theSindex it has a DataRank of 0. It has been cited 145 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: HHSN268201100001I
National Institute of Allergy and Infectious Diseases
Grant: R01AI137276
National Institute of Allergy and Infectious Diseases
Grant: U19AI111825
European Union Seventh Framework Program
Grant: FP7/2007-2011
Department of Health and Human Services
Grant: HHSO100201600010C
Howard Hughes Medical Institute/Wellcome Trust
Grant: 208710/Z/17/Z
National Institutes of Health
Grant: 5U19AI111825-02
Modulation of Human Dendritic Cell Development by Adjuvants and Vaccines
Wellcome Trust
Grant: 208710
To B or not to B: Investigation of B cell responses during secondary flavivirus infection
National Institutes of Health
Grant: 5R01AI137276-08
Mechanisms of Antibody-Dependent Enhancement of Dengue Disease
Fields of Study
Keywords
Sustainable Development Goals